Dose-finding Study of WS6788A, DS37-4 and H10407 Enterotoxigenic Escherichia Coli (ETEC) Challenge Strains
Dose-finding Study of WS6788A, DS37-4 and H10407 Enterotoxigenic E. Coli (ETEC) Challenge Strains That Express Colonization Factors CS17 and CFA/I
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
A PHASE1 clinical study on Diarrhea, this trial is completed. The trial is conducted by Henry M. Jackson Foundation for the Advancement of Military Medicine and has accumulated 7 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Aug 2019 — Jan 2021 [monthly]
Completed PHASE1
-
Jun 2018 — Aug 2019 [monthly]
Completed PHASE1
▶ Show 2 earlier versions
-
May 2017 — Jun 2018 [monthly]
Completed PHASE1
-
Jan 2017 — May 2017 [monthly]
Completed PHASE1
First recorded
Sep 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Johns Hopkins Bloomberg School of Public Health
- Naval Medical Research Center
- U.S. Army Medical Research and Development Command
- Walter Reed Army Institute of Research (WRAIR)
For direct contact, visit the study record on ClinicalTrials.gov .